You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Tappan Street Partners | 0 | 2,231,577 | 0 | 2,231,577 | 2,231,577 | 4.95% |
| Tappan Street Partners Fund | 0 | 1,540,000 | 0 | 1,540,000 | 1,540,000 | 3.42% |
| Tappan Street Partners Ideas Fund | 0 | 691,577 | 0 | 691,577 | 691,577 | 1.53% |
| Prasad Phatak | 67,107 | 2,231,577 | 67,107 | 2,231,577 | 2,298,684 | 5.10% |
Follow Prasad Phatak And Chris Koranda's Tappan Street Partners
Page 1 of 9 – SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under
the Securities Exchange Act of 1934*
(Amendment
No. 1)
| Peregrine Pharmaceuticals, Inc. |
| (Name
|
| Common Stock ($0.001 par value) |
| (Title
|
| 713661502 |
| (CUSIP
|
| July 11, 2017 |
| (Date of Event Which Requires Filing of this Statement) |
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
| ☐ | Rule 13d-1(b) | |
| ☒ | Rule 13d-1(c) | |
| ☐ | Rule 13d-1(d) |
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided
in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).
